Literature DB >> 133759

Fibrin subunits in venous and arterial thromboembolism.

P J Gaffney, M Brasher, K Lord, C J Strachan, A R Wilkinson, V V Kakkar, M F Scully.   

Abstract

The subunit fibrin composition of thrombi of both venous and arterial origin was examined by sodium dodecyl sulphate gel electrophoresis. The thrombi were recovered by surgical intervention and all had the same fibrin subunit composition. The alpha chains were cross-linked as alpha-chain polymers alpha (p), the gamma chains as gamma-chain dimers (gamma-gamma) while the beta chains were not crosslinked; a further subunit of molecular weight 33 000 was shown to be present in all the fibrins examined and was a degradation fragment of the beta or gamma chains. This data suggests that the crosslinked alpha chains are rate limiting to the lysis of thrombi in vivo. The digestion of pulmonary emboli by plasmin yielded soluble degradation products which were identified as D dimer and E, the latter fragments being the major products obtained by the lysis of in-vitro made plasma clots. The similarity of the composition and lysis of thrombus fibrin to that formed in vitro augurs well for the justification of in-vitro research on mechanisms in thrombolysis.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 133759     DOI: 10.1093/cvr/10.4.421

Source DB:  PubMed          Journal:  Cardiovasc Res        ISSN: 0008-6363            Impact factor:   10.787


  6 in total

Review 1.  Roles of transglutaminases in cardiac and vascular diseases.

Authors:  David C Sane; Jimmy L Kontos; Charles S Greenberg
Journal:  Front Biosci       Date:  2007-01-01

2.  Breakdown products of fibrin and fibrinogen: molecular mechanisms and clinical implications.

Authors:  P J Gaffney
Journal:  J Clin Pathol Suppl (R Coll Pathol)       Date:  1980

3.  Fibrinogen influx and accumulation of cross-linked fibrin in healing wounds and in tumor stroma.

Authors:  L F Brown; L Van de Water; V S Harvey; H F Dvorak
Journal:  Am J Pathol       Date:  1988-03       Impact factor: 4.307

4.  Dominant role of αIIbβ3 in platelet interactions with cross-linked fibrin fragment D-dimer.

Authors:  Lorena Buitrago; Hina Zafar; Yixiao Zhang; Jihong Li; Thomas Walz; Barry S Coller
Journal:  Blood Adv       Date:  2020-07-14

Review 5.  Tissue plasminogen activator for thrombolytic therapy: expectation versus reality.

Authors:  P J Gaffney
Journal:  J R Soc Med       Date:  1992-11       Impact factor: 18.000

6.  Platelet binding to polymerizing fibrin is avidity driven and requires activated αIIbβ3 but not fibrin cross-linking.

Authors:  Lorena Buitrago; Samuel Lefkowitz; Ohad Bentur; Julio Padovan; Barry Coller
Journal:  Blood Adv       Date:  2021-10-26
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.